retatrutide glp-1 gip glucagon agonist Api Triple Receptor Reatatrutide 5mg

doi: 10.1152/ajpheart.00146.2010 41 MilanGRomanelloVPescatoreFArmaniAPaikJHFrassonLet al

This mimics the body's natural pulsatile release of growth hormone, which is precisely the mechanism this peptide blend is designed to stimulate

Both Lilly and Novo Nordisk are testing pill forms of these drugs (currently they are given once weekly by subcutaneous injection)

It interacts with the GHS-R1a receptor, influencing GH pulsatility and appetite-related signaling pathways

doi:10.1002/hup.544

The short answer: You can begin with your primary care clinician, a specialist in obesity medicine, or in some cases a telehealth provider